Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bradley Pharmaceuticals

Bradley Pharmaceuticals
1985 FOUNDED
M&A STATUS
201-300 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Operator of a specialty pharmaceutical company. The company markets to niche physician specialties in the U.S. and international markets. The company commercializes brands, develops new products through lifecycle management and in-licenses phase II and phase III drugs with long-term intellectual property protection. It specializes in pharmaceuticals for dermatology, podiatry, gastroenterology, women's health, respiratory and internal medicine products.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 383 Route 46 West
  • Fairfield, NJ 07004
  • United States

Bradley Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bradley Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Bradley Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Daniel Glassman President & Chief Executive Officer & Founder
Brent Lenczycki Chief Financial Officer & Vice President